# Abeona Therapeutics (ABEO) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/ABEO
## Company Profile
- Ticker: ABEO
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
- Tags: Gene Therapy, Rare Disease Gene Therapy, Rare Disease
## Stock Data
- Close: 7.46 USD
- Market cap: 324302369.36 USD
- Last updated: 2026-08-12
## Business Overview
### Cell and Gene Therapy Company
Abeona Therapeutics develops and commercializes genetic medicines for serious diseases.
### ZEVASKYN
ZEVASKYN is an autologous, gene-corrected epidermal sheet therapy for wounds in recessive dystrophic epidermolysis bullosa and provides Abeona with a commercial cell-therapy platform.
### ABO-701
ABO-701 is an engineered T-cell program targeting PSMA in solid tumors and uses synthetic immune-receptor technology intended to improve selectivity and activity.
## Why The Stock Is Moving

The latest monitored company update is “Abeona Therapeutics® Reports Second Quarter 2026 Results and Provides Business Update.” The corresponding closing-price reaction is not yet available.

## Recent News
- 2026-08-13 11:30 EST — [Abeona Therapeutics® Reports Second Quarter 2026 Results and Provides Business Update](https://biopharmsignal.com/news/ABEO/abeona-therapeutics-reports-second-quarter-2026-results-and-provides-business-up-5235c160) — Source: Abeona Therapeutics
- 2026-08-06 11:30 EST — [Abeona Therapeutics® to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026](https://biopharmsignal.com/news/ABEO/abeona-therapeutics-to-host-second-quarter-2026-financial-results-conference-cal-9a5111ba) — Source: Abeona Therapeutics
- 2026-08-04 11:30 EST — [CMS Grants New Technology Add-On Payment (NTAP) Status for ZEVASKYN®](https://biopharmsignal.com/news/ABEO/cms-grants-new-technology-add-on-payment-ntap-status-for-zevaskyn-300aae33) — Source: Abeona Therapeutics
- 2026-08-03 11:30 EST — [Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/ABEO/abeona-therapeutics-announces-new-employee-inducement-grants-under-nasdaq-listin-bd27d591) — Source: Abeona Therapeutics
- 2026-07-21 11:30 EST — [Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®](https://biopharmsignal.com/news/ABEO/cincinnati-children-s-activated-as-the-seventh-qualified-treatment-center-for-ze-8382d043) — Source: Abeona Therapeutics